A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.

被引：3
|
作者：
Owen, Carina N.
Larkin, James M. G.
Shoushtari, Alexander Noor
Carlino, Matteo S.
Blank, Christian U.
Lee, Belinda
Mangana, Joanna
Atkinson, Victoria
Millward, Michael
Zaman, Farzana
Young, Arissa
Khattak, Muhammad Adnan
Patel, Sapna Pradyuman
Hoeller, Christoph
Hersey, Peter
Chauhan, Dharmisha
Palmieri, David James
Lo, Serigne
Menzies, Alexander M.
Long, Georgina V.
机构：
[1] Melanoma Inst Australia, Sydney, NSW, Australia
[2] Royal Marsden NHS Fdn Trust, London, England
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Univ Sydney, Melanoma Inst Australia, Westmead Hosp, Sydney, NSW, Australia
[5] Univ Sydney, Melanoma Inst Australia, Blacktown Hosp, Sydney, NSW, Australia
[6] Netherlands Canc Inst, Amsterdam, Netherlands
[7] Imperial Coll NHS Hosp, London, England
[8] Univ Hosp Zurich, Zurich, Switzerland
[9] Univ Queensland, Brisbane, Qld, Australia
[10] Sch Med & Pharmacol, Nedlands, WA, Australia
[11] The Alfred, Melbourne, Vic, Australia
[12] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[13] Univ Western Australia, Fiona Stanley Hosp, Perth, WA, Australia
[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[15] Med Univ Vienna, Vienna, Austria
[16] Univ Newcastle, Newcastle, NSW, Australia
[17] Westmead Hosp, Sydney, NSW, Australia
[18] Imam Abdulrahman Bin Faisal Univ, IRMC, Dammam, Saudi Arabia
[19] Univ Sydney, Royal North Shore Hosp, Melanoma Inst Australia, Sydney, NSW, Australia
[20] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[21] Royal North Shore Hosp, Sydney, NSW, Australia
[22] Mater Hosp, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.9502
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9502
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Management of melanoma recurrence following adjuvant anti-PD1 therapy
    Owen, C.
    Palmieri, D.
    Guminski, A.
    Carlino, M. S.
    Menzies, A. M.
    Long, G. V.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] Metabolic factors affecting response to adjuvant anti-PD1 therapy for melanoma
    Bruno, Sabrina
    Knight, Andrew David
    Wang, Hong
    Sander, Cindy
    Karapetyan, Lilit
    Kirkwood, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Pathologic Features of Renal Carcinoma Following Anti-PD1 Therapy. A Clinicopathologic Analysis of 12 Cases
    Samdani, Rashmi
    Rao, Priya
    [J]. MODERN PATHOLOGY, 2017, 30 : 254A - 254A
  • [4] Pathologic Features of Renal Carcinoma Following Anti-PD1 Therapy. A Clinicopathologic Analysis of 12 Cases
    Samdani, Rashmi
    Rao, Priya
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 254A - 254A
  • [5] Off treatment survival (OTS) in patients (pts) with advanced melanoma after anti-PD1 therapy.
    Christiansen, Shelly Ann
    Swoboda, David
    Gardner, Kellie
    Rapisuwon, Suthee
    Atkins, Michael B.
    Gibney, Geoffrey Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Predicting the response to anti-PD1 therapy in metastatic melanoma
    Heinzerling, Lucie
    Kirchberger, Michael Constantin
    Walter, Lisa
    Schuler, Gerold
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S576 - S579
  • [7] A MULTICENTER CHARACTERIZATION OF CHRONIC TOXICITIES FOLLOWING ADJUVANT ANTI-PD-1 THERAPY FOR HIGH RISK RESECTED MELANOMA
    Patrinely, James
    Johnson, Rebecca
    Lawless, Aleigha
    Bhave, Prachi
    Sawyers, Amelia
    Dimitrova, Maya
    Yeohc, Hui
    Palmeri, Marisa
    Davis, Elizabeth
    Rapisuwon, Suthee
    Long, Georgina
    Haydon, Andrew
    Osman, Iman
    Mehnert, Janice
    Carlino, Matteo
    Sullivan, Ryan
    Menzies, Alexander
    Johnson, Douglas
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A114 - A115
  • [8] Combined Therapy with Anti-PD1 and BRAF and/or MEK Inhibitor for Advanced Melanoma: A Multicenter Cohort Study
    Huynh, Sandra
    Mortier, Laurent
    Dutriaux, Caroline
    Maubec, Eve
    Boileau, Marie
    Dereure, Olivier
    Leccia, Marie-Therese
    Arnault, Jean-Philippe
    Brunet-Possenti, Florence
    Aubin, Francois
    Dreno, Brigitte
    Beylot-Barry, Marie
    Lebbe, Celeste
    Lefevre, Wendy
    Delyon, Julie
    [J]. CANCERS, 2020, 12 (06) : 1 - 11
  • [9] Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
    Nakamura, Y.
    Namikawa, K.
    Yoshino, K.
    Yoshikawa, S.
    Uchi, H.
    Goto, K.
    Fukushima, S.
    Kiniwa, Y.
    Takenouchi, T.
    Uhara, H.
    Kawai, T.
    Hatta, N.
    Funakoshi, T.
    Teramoto, Y.
    Otsuka, A.
    Doi, H.
    Ogata, D.
    Matsushita, S.
    Isei, T.
    Hayashi, T.
    Shibayama, Y.
    Yamazaki, N.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (09) : 1198 - 1206
  • [10] Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
    Owen, C. N.
    Shoushtari, A. N.
    Chauhan, D.
    Palmieri, D. J.
    Lee, B.
    Rohaan, M. W.
    Mangana, J.
    Atkinson, V
    Zaman, F.
    Young, A.
    Hoeller, C.
    Hersey, P.
    Dummer, R.
    Khattak, M. A.
    Millward, M.
    Patel, S. P.
    Haydon, A.
    Johnson, D. B.
    Lo, S.
    Blank, C. U.
    Sandhu, S.
    Carlino, M. S.
    Larkin, J. M. G.
    Menzies, A. M.
    Long, G., V
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (08) : 1075 - 1082
12345